Company intelligence / Profile preview

In Vitro ADMET Laboratories

Columbia, Maryland, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

IVAL is a key global CRO specializing in in vitro ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicology) testing, pioneering the use of human hepatocytes and organotypic models such as the IdMOC platform to support preclinical drug development for regulatory submissions. The company has enabled successful IND and NDA filings and partner drug/biologic approvals by providing highly predictive human-relevant data on drug properties and safety.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Taconic (humanized mouse/preclinical development models)

Beyond the preview

Go deeper on In Vitro ADMET Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on In Vitro ADMET Laboratories.

Explore the full profile